Pages that link to "Q38949880"
Jump to navigation
Jump to search
The following pages link to Receptors for luteinizing hormone-releasing hormone (GnRH) as therapeutic targets in triple negative breast cancers (TNBC). (Q38949880):
Displaying 6 items.
- Could gonadotropin-releasing hormone analogs be helpful in the treatment of triple-negative breast cancer? (Q47848539) (← links)
- Exploring 3D structure of human gonadotropin hormone receptor at antagonist state using homology modeling, molecular dynamic simulation, and cross-docking studies (Q51550199) (← links)
- Luteinizing hormone-releasing hormone peptide tethered nanoparticulate system for enhanced antitumoral efficacy of paclitaxel. (Q52880516) (← links)
- Synthesis and in vitro anti-cancer evaluation of luteinizing hormone-releasing hormone-conjugated peptide. (Q53473716) (← links)
- Improved In Vivo Anti-Tumor and Anti-Metastatic Effect of GnRH-III-Daunorubicin Analogs on Colorectal and Breast Carcinoma Bearing Mice (Q90312191) (← links)
- Weighted correlation network analysis of triple-negative breast cancer progression: Identifying specific modules and hub genes based on the GEO and TCGA database (Q92683710) (← links)